Clinical diagnosis, monitoring and biomarkers in ILDs M. Kreuter (Heidelberg, Germany)
| |
Radiologic evaluation of ILDs C.P. Heussel (Heidelberg, Germany)
| |
Pathology of ILDs A. Warth (Heidelberg, Germany)
| |
Bronchoscopic and surgical diagnostic procedures in ILDs F. Herth (Heidelberg, Germany)
| |
Idiopathic pulmonary fibrosis (IPF) J. Behr (Munich, Germany)
| |
Non-IPF idiopathic interstitial pneumonia (IIPs) T. Maher (London, United Kingdom)
| |
Combined pulmonary fibrosis and emphysema syndrome, DIP and RB-ILD V. Cottin (Lyon, France)
| |
Sarcoidosis and berylliosis T. Geiser (Bern, Switzerland)
| |
Hypersensitivity pneumonitis M. Vasakova (Prague, Czech Republic)
| |
Paediatric interstitial lung disease E. Eber (Graz, Austria)
| |
Occupational and drug-induced ILDs W. Wuyts (Leuven, Belgium)
| |
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias) B. Crestani (Paris, France)
| |
Connective tissue disease-associated lung disease M. Kreuter (Heidelberg, Germany)
| |
Pulmonary vasculitis T. Maher (London, United Kingdom)
| |
Pulmonary hypertension and cardiovascular diseases in ILD V. Cottin (Lyon, France)
| |
Genetics of ILD B. Crestani (Paris, France)
| |
Pathogenesis of ILD O. Eickelberg (Munich, Germany)
| |
Cell therapy in ILD T. Geiser (Bern, Switzerland)
| |
Future treatment modalities W. Wuyts (Leuven, Belgium)
| |
Future developments in IPF biomarkers O. Eickelberg (Munich, Germany)
| |
Lung cancer in ILD F. Herth (Heidelberg, Germany), N. Kahn (Heidelberg, Germany)
| |
GERD in ILDs M. Kreuter (Heidelberg, Germany)
| |
The role of ILD nurses & patient support groups: optimising care for ILD A.M. Russell (London, United Kingdom)
| |
Pulmonary rehabilitation T. Geiser (Bern, Switzerland)
| |
Managing end stage disease in ILDs M. Vasakova (Prague, Czech Republic)
| |
Lung transplantation J. Egan (Dublin, Ireland), P. Riddell (Dublin, Ireland)
| |